The Age of Antivirals New drug targets and tools for identifying promising drugs suggest treatments for Covid-19—and future diseases. Published April 18, 2022 COVID-19 Drugs Infectious Diseases Anthony Leung (left) and research technologist Junlin Zhuo, ScM, inspect a plate of bacteria that produce proteins for ADPr-Glo. Photo by Chris Hartlove Related Content Medicare Program Spent $1.8 Billion in 2019 on Drugs Without Confirmed Clinical Benefits May 24, 2022 Where We Are in the Pandemic May 24, 2022 What You Need to Know About Monkeypox May 23, 2022 How COVID-19 Created a ‘Watershed’ Moment for Wastewater Surveillance May 13, 2022 Federal Subsidies Kept COVID-Strapped Hospitals Financially Stable In 2020, First Year of Pandemic May 13, 2022
Anthony Leung (left) and research technologist Junlin Zhuo, ScM, inspect a plate of bacteria that produce proteins for ADPr-Glo. Photo by Chris Hartlove
Medicare Program Spent $1.8 Billion in 2019 on Drugs Without Confirmed Clinical Benefits May 24, 2022
Federal Subsidies Kept COVID-Strapped Hospitals Financially Stable In 2020, First Year of Pandemic May 13, 2022